Varex Imaging Corp. (VREX)
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
$18.51-0.05%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
QuarterlyIQ Insights · VREX
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -7.8% |
| Our one-year growth estimate | diamond | 5.9% |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
Usually moved in the same direction.
Price observations: 365 days
Most sensitive to the broad stock market.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Growth built into the price is above our model estimate.
The price assumes 13.8 percentage points less one-year growth.
The one-year revenue growth assumption on Valuation.
Model as of 2026-09-04 · Compared with 87 industry peers · Company calendar date is not available
VREX — officer change
Dated 2026-08-10
The filing details the acceleration of equity awards for named executives in connection with a merger, not a change in management roles or departures.
Why it matters: Good capital allocation helps the company grow and stay stable. It affects future investments.
Watch forManagement has a clear plan for spending money in Q3 earnings.
Also watch forNo news or unclear plans on how money will be spent in Q3 earnings.
Why it matters: Growth in this area is key for Varex's total revenue and market position.
Supportive ifMedical segment revenue grew over 2% compared to last year.
Worry ifMedical segment revenue grew less than 0% compared to last year.
Why it matters: Hitting this EPS target shows better profits and matches the guidance.
Supportive ifNon-GAAP EPS for Q3 is reported at $0.15 or higher.
Worry ifNon-GAAP EPS for Q3 is below $0.15.
Why it matters: Rising cash outflows may show problems with cash management and how well the company runs.
Worry ifCash outflows from operations were over $2 million in Q3.
Less concerning ifCash outflows from operations drop or stay below $2 million.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$103 on $10,000 · ±1.0% | How much price usually moves either way. |
| Bad day | $389 loss on $10,000 · 3.9% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $3,510 loss on $10,000 · 35.1% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: News on tariff refunds can change revenue and profits a lot.
Watch forVarex gets more tariff refunds that help Q3 results.
Also watch forNo new tariff refunds come in, hurting Q3 results.
Why it matters: Health Care sector growth impacts Varex's performance. A rebound can boost revenue.
Supportive ifHealth Care sector reports revenue growth above 10% year over year.
Worry ifSector growth is under 5%, showing ongoing challenges.
Why it matters: If sector revenue growth stays above average, it helps Varex grow in a good market.
Watch forSector revenue growth is above average.
Also watch forSector revenue growth is below average.
Why it matters: Stable cash flows show better financial health. This helps support growth plans.
Supportive ifCash outflows from operations are $0 or positive.
Worry ifCash outflows from operations reported worse than -$2 million.
Why it matters: Management targets non-GAAP EPS of $0.80-$1.00 for FY 2026. This shows good cost control.
Supportive ifNon-GAAP EPS was above $0.30 in Q4, showing recovery.
Worry ifNon-GAAP EPS remains below $0.15 in Q4, showing ongoing challenges.
Why it matters: Approval is needed to finish the acquisition. It affects Varex's future plans.
Supportive ifStockholders vote for the acquisition at the special meeting.
Worry ifStockholders vote against the acquisition or the meeting gets delayed.
Why it matters: The earnings report will show if Varex can improve its loss-making status. Investors will look for signs of recovery.
Watch forQ2 earnings show smaller losses or a return to making money.
Also watch forQ2 earnings show losses that are worse than expected, indicating ongoing struggles.
Why it matters: Meeting this target confirms management's growth strategy and market demand. It is a key indicator of financial health.
Supportive ifQ4 revenue guidance aligns with the full year target of $860 million to $880 million.
Worry ifGuidance falls below the lower end of the $860 million target.
Why it matters: Hitting this EPS target is key for investor trust. It shows how well the company controls costs.
Supportive ifNon-GAAP EPS for Q4 meets or exceeds the target range of $0.80 to $1.00.
Worry ifNon-GAAP EPS falls below $0.80 for Q4.
Why it matters: Positive cash flow is important for operations and growth. It shows financial health and good capital management.
Supportive ifCash flow from operations is positive after a negative $2 million in Q2.
Worry ifCash flow from operations remains negative or worsens.